Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries
Continent/Country | Tested/Total (%) | Rest of the world Tested/Total (%) | P |
|---|---|---|---|
Europe | 1078/2344 (46%) | 172/1358 (12.7%) | < 0.0001 |
North America | 105/529 (19.8%) | 1145/3173 (36.1%) | < 0.0001 |
Asia | 44/415 (10.6%) | 1206/3287 (36.7%) | < 0.0001 |
Oceania | 3/40 (7.5%) | 1247/3662 (34.1%) | < 0.0001 |
Africa | 9/156 (5.8%) | 1241/3546 (35%) | < 0.0001 |
South America | 11/218 (5%) | 1239/3484 (35.6%) | < 0.0001 |
Spain | 455/643 (70.8%) | 795/3059 (26%) | < 0.0001 |
Italy | 293/459 (63.8%) | 957/3243 (29.5%) | < 0.0001 |
Greece | 54/87 (62.1%) | 1196/3615 (33.1%) | < 0.0001 |
France | 40/66 (60.6%) | 1210/3636 (33.3%) | < 0.0001 |
Portugal | 58/134 (43.3%) | 1192/3568 (33.4%) | 0.018 |
Bulgaria | 21/51 (41.2%) | 1229/3651 (33.7%) | 0.260 |
Denmark | 26/89 (29.2%) | 1224/3613 (33.9%) | 0.358 |
Germany | 40/173 (23.1%) | 1210/3529 (34.3%) | 0.002 |
US | 102/477 (21.4%) | 1148/3225 (35.6%) | < 0.0001 |
Serbia | 10/56 (17.9%) | 1240/3646 (34%) | 0.011 |
Croatia | 16/103 (15.5%) | 1234/3599 (34.3%) | < 0.0001 |
UK | 20/186 (10.8%) | 1230/3516 (35%) | < 0.0001 |
Argentina | 11/190 (5.8%) | 1239/3512 (35.3%) | < 0.0001 |
Pakistan | 6/109 (5.5%) | 1244/3593 (34.6%) | < 0.0001 |